Bristol Myers Squibb Co. (BMY)
51.14
+0.49
(+0.97%)
USD |
NYSE |
Dec 10, 13:53
Bristol Myers Squibb Total Liabilities (Quarterly): 78.29B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 80.52B |
| Gilead Sciences, Inc. | 37.08B |
| Johnson & Johnson | 113.54B |
| Eli Lilly & Co. | 91.08B |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.89B |
| Shareholders Equity (Quarterly) | 18.55B |
| Debt to Equity Ratio | 2.751 |
| Current Ratio | 1.266 |
| Net Debt Paydown Yield | 0.65% |